We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

44 hedge funds and large institutions have $282M invested in Aquestive Therapeutics in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64.5% more ownership

Funds ownership: 0% → 64.5% (+64%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
Crestline Management
Texas
+$190M
2
PA
Perceptive Advisors
New York
+$19M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$13.5M
4
BlackRock
BlackRock
New York
+$7.77M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.58M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
1
Crestline Management
Texas
$201M +$190M +11,503,294 New
PA
2
Perceptive Advisors
New York
$20.1M +$19M +1,150,000 New
AllianceBernstein
3
AllianceBernstein
Tennessee
$14.3M +$13.5M +817,992 New
BlackRock
4
BlackRock
New York
$8.25M +$7.77M +471,404 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.05M +$7.58M +460,032 New
PWAM
6
Park West Asset Management
California
$6.9M +$6.49M +394,000 New
Massachusetts Financial Services
7
Massachusetts Financial Services
Massachusetts
$5.3M +$4.99M +302,946 New
AC
8
Ascend Capital
California
$3.16M +$2.98M +180,610 New
WA
9
Wasatch Advisors
Utah
$2.54M +$2.4M +145,373 New
BBA
10
Baker Bros. Advisors
New York
$1.74M +$1.64M +99,600 New
SFM
11
Sphera Funds Management
Israel
$1.67M +$1.57M +95,300 New
Northern Trust
12
Northern Trust
Illinois
$1.01M +$952K +57,752 New
OAM
13
Oxford Asset Management
United Kingdom
$816K +$773K +46,923 New
Two Sigma Investments
14
Two Sigma Investments
New York
$773K +$728K +44,156 New
DIM
15
DC Investments Management
Virginia
$655K +$616K +37,384 New
BPIM
16
Brant Point Investment Management
New York
$622K +$585K +35,512 New
EGM
17
Engineers Gate Manager
New York
$464K +$437K +26,511 New
Citadel Advisors
18
Citadel Advisors
Florida
$451K +$425K +25,780 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$435K +$410K +24,898 New
Goldman Sachs
20
Goldman Sachs
New York
$376K +$354K +21,454 New
LCM
21
Landscape Capital Management
New Jersey
$357K +$336K +20,381 New
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$350K +$330K +20,000 New
State Street
23
State Street
Massachusetts
$260K +$244K +14,800 New
KeyBank National Association
24
KeyBank National Association
Ohio
$239K +$225K +13,644 New
BCM
25
BlueCrest Capital Management
Jersey
$238K +$224K +13,598 New
1
2

AQST Hedge Fund Activity: Q3 2018 in Review

44 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q3 2018, worth a combined $282M.

Buyers outnumbered sellers: 44 funds opened new AQST positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Crestline Management, opening a new position worth an estimated $190M.

  • 44 institutional investors held Aquestive Therapeutics (AQST) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $282M of Aquestive Therapeutics stock for Q3 2018.
  • 44 funds opened new Aquestive Therapeutics positions in Q3 2018 and 0 closed out, a net change of +44 holders.
  • The largest Aquestive Therapeutics buyer in Q3 2018 was Crestline Management, an estimated $190M added.

Based on aggregated 13F filings for Q3 2018.